A p38 /
JNK nuclear translocation — blocking peptide may be therapeutic in various cancers and inflammation - associated diseases.
Not exact matches
Together, these results support the use of the
nuclear translocation of p38 and
JNK as a novel drug target to treat various cancers and inflammation - induced diseases.
Previously, we determined that
nuclear translocation of the MAPKs p38 and
JNK involves binding to heterodimers comprising importin 3 and either importin 7 or importin 9.
The PERY peptide specifically blocked the interaction of p38 and
JNK with the importins, restricted their
nuclear translocation, and inhibited phosphorylation of their
nuclear (but not cytoplasmic) substrates.